February 20, 2026

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Unpacking the 104% Potential Upside

Trevi Therapeutics, Inc. (NASDAQ: TRVI) emerges as a compelling player in the biotechnology sector with its focus on pioneering treatments for chronic cough and pruritus. The..

Prothena Corporation plc (PRTA) Stock Analysis: A 125% Upside Potential in the Biotech Sector?

Investors eyeing the biotechnology sector may find Prothena Corporation plc (NASDAQ: PRTA) a compelling prospect, thanks to its significant upside potential and thriving pipeline in neurodegenerative..

Verastem, Inc. (VSTM) Stock Analysis: Navigating the 179% Potential Upside in the Biotech Sector

For investors with a keen eye on biotechnology stocks, Verastem, Inc. (NASDAQ: VSTM) presents a particularly intriguing opportunity within the healthcare sector. With a market capitalization..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Exploring a 104.55% Potential Upside in Gene Therapy Innovations

Rocket Pharmaceuticals, Inc. (RCKT) is a promising player in the biotechnology sector, focusing on the development of transformative gene therapies for rare and devastating diseases. With..

Orthofix Medical Inc. (OFIX) Stock Analysis: A 41.61% Potential Upside for Investors in the Medical Device Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a key player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors eyeing growth in the..

AtaiBeckley Inc. (ATAI): Biotech Disruptor with a Promising 226% Upside Amid Mental Health Breakthroughs

AtaiBeckley Inc. (NASDAQ: ATAI), a rising star in the biotechnology sector, is capturing investor attention with its groundbreaking approach to mental health treatments. Specializing in the..

Personalis, Inc. (PSNL) Stock Analysis: A 26.66% Potential Upside Amidst Strategic Collaborations in Cancer Genomics

Personalis, Inc. (PSNL), a prominent player in the healthcare sector’s diagnostics and research industry, is gaining attention for its innovative cancer genomic tests and services. With..

Humacyte, Inc. (HUMA) Stock Analysis: Unpacking a 570% Potential Upside

Humacyte, Inc. (NASDAQ: HUMA), a burgeoning player in the biotechnology sector, has captured the attention of investors with its innovative approach to healthcare solutions. Specializing in..

Precigen, Inc. (PGEN): Investor Outlook on a Biotech with 88% Potential Upside

Precigen, Inc. (NASDAQ: PGEN) has recently captured the attention of investors due to its significant growth potential within the biotechnology sector. The company, headquartered in Germantown,..

AbCellera Biologics Inc. (ABCL) Investor Outlook: Potential Upside of 205% Amidst Biotech Innovations

AbCellera Biologics Inc. (NASDAQ: ABCL), a prominent player in the biotechnology sector, is making waves with its robust pipeline of antibody-based medicines developed to address unmet..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a Potential 778% Upside for Biotech Investors

Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology company, has captured the attention of investors with its promising immunotherapy developments and impressive potential upside. With a market..

REGENXBIO Inc. (RGNX) Stock Analysis: Examining a 238% Potential Upside in the Biotech Sector

For investors hunting for opportunities in the healthcare sector, REGENXBIO Inc. (NASDAQ: RGNX) presents a compelling case with its strong potential upside. The biotechnology company, headquartered..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Unpacking Its 239% Potential Upside

Bicycle Therapeutics plc (NASDAQ: BCYC), a clinical-stage pharmaceutical innovator, is capturing attention with its ambitious pipeline and robust analyst backing. With a potential upside of 239.35%,..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a 278% Potential Upside

For investors venturing into the dynamic landscape of biotechnology, Tectonic Therapeutic, Inc. (NASDAQ: TECX) presents a compelling opportunity characterized by innovation and substantial growth potential. With..

Septerna, Inc. (SEPN) Stock Analysis: A Biotech Powerhouse with a 25% Upside Potential

Septerna, Inc. (NASDAQ: SEPN) is capturing the attention of investors in the healthcare sector with its significant growth potential and innovative contributions to biotechnology. As a..

EyePoint, Inc. (EYPT) Stock Analysis: Exploring a 145% Potential Upside in the Biotech Sector

EyePoint, Inc. (NASDAQ: EYPT) is capturing the attention of investors with its significant growth potential in the biotechnology sector. Specializing in the development and commercialization of..

Myriad Genetics, Inc. (MYGN): Investor Outlook on a Healthcare Innovator with 85% Upside Potential

Myriad Genetics, Inc. (NASDAQ: MYGN), a key player in the healthcare sector, continues to capture attention in the diagnostics and research industry. As the company navigates..

CorMedix Inc. (CRMD) Stock Analysis: Potential Upside of Over 100% Amidst Robust Revenue Growth

CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company headquartered in Berkeley Heights, New Jersey, is catching the attention of investors with its substantial revenue growth and an..

Sionna Therapeutics, Inc. (SION) Stock Analysis: A High-Stakes Bet on Biotech Innovation with 20.13% Upside Potential

Sionna Therapeutics, Inc. (SION), a clinical-stage biopharmaceutical company, stands at the forefront of innovation in the biotechnology sector, focusing on groundbreaking treatments for cystic fibrosis (CF)...

iRadimed Corporation (IRMD) Stock Analysis: A High-Growth Medical Device Leader with an 18.98% Upside

Investors seeking exposure to the robust healthcare sector may find iRadimed Corporation (NASDAQ: IRMD) an intriguing opportunity. As a leader in the niche market of MRI-compatible..

Search

Funds

February 20, 2026

Search

Funds

February 20, 2026

FTSE 100

Funds